Literature DB >> 22675010

A rare case of non-insulinoma pancreatic hypoglycaemia syndrome (niphs) in an adult due to localised islet cell hyperplasia-successfully managed by enucleation.

Hemanta K Nayak1, Arpit Sothwal, Nishant Raizaida, Mradul kumar Daga, Anil kumar Agarwal, Garima Durga.   

Abstract

Persistent hyperinsulinemic hypoglycaemia is caused most commonly by an insulinoma in adults or by nesidioblastosis in neonates. In adults, localised islet cell hyperplasia is a rare disorder characterised by localised proliferation of islet cells. The authors present the case of a previously healthy non-obese middle aged female with new-onset severe hypoglycaemia. Laboratory findings confirmed a case of hyperinsulinemic hypoglycaemia. Endoscopic ultrasonography, intra-arterial calcium stimulation test and intraoperative ultrasonography showed a lesion in the uncinate process that was enucleated. Rest of the pancreas was normal. Histological examination and immunostaining of the resected tissue revealed pancreatic tissue with maintained acinar pattern consistent with diagnosis of localised islet cell hyperplasia. The patient did not have further episodes of hypoglycaemia following the procedure. Localised islet cell hyperplasia with such a very high insulin level is exceedingly rare in adult populations and not reported in literature. This diagnosis cannot be easily made through routine diagnostic laboratory or radiological procedures and likely requires a histological diagnosis. Management of this rare entity is by enucleation.

Entities:  

Mesh:

Year:  2011        PMID: 22675010      PMCID: PMC3207758          DOI: 10.1136/bcr.07.2011.4554

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Tumor-induced hypoglycemia.

Authors:  D Le Roith
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

2.  Hypoglycemic disorders.

Authors:  F J Service
Journal:  N Engl J Med       Date:  1995-04-27       Impact factor: 91.245

3.  Insulinoma and islet cell hyperplasia: value of the calcium intraarterial stimulation test when findings of other preoperative studies are negative.

Authors:  P L Pereira; A J Roche; G W Maier; P E Huppert; F Dammann; C T Farnsworth; S H Duda; C D Claussen
Journal:  Radiology       Date:  1998-03       Impact factor: 11.105

4.  Noninsulinoma pancreatogenous hypoglycemia syndrome: an update in 10 surgically treated patients.

Authors:  G B Thompson; F J Service; J C Andrews; R V Lloyd; N Natt; J A van Heerden; C S Grant
Journal:  Surgery       Date:  2000-12       Impact factor: 3.982

5.  Noninsulinoma pancreatogenous hypoglycemia: a novel syndrome of hyperinsulinemic hypoglycemia in adults independent of mutations in Kir6.2 and SUR1 genes.

Authors:  F J Service; N Natt; G B Thompson; C S Grant; J A van Heerden; J C Andrews; E Lorenz; A Terzic; R V Lloyd
Journal:  J Clin Endocrinol Metab       Date:  1999-05       Impact factor: 5.958

6.  Causes, management and morbidity of acute hypoglycaemia in adults requiring hospital admission.

Authors:  S P Hart; B M Frier
Journal:  QJM       Date:  1998-07

7.  Prospective study of the use of intraarterial secretin injection and portal venous sampling to localize duodenal gastrinomas.

Authors:  A K Thom; J A Norton; J L Doppman; D L Miller; R Chang; R T Jensen
Journal:  Surgery       Date:  1992-12       Impact factor: 3.982

8.  Insulinomas: localization with selective intraarterial injection of calcium.

Authors:  J L Doppman; D L Miller; R Chang; T H Shawker; P Gorden; J A Norton
Journal:  Radiology       Date:  1991-01       Impact factor: 11.105

Review 9.  Imaging islet cell tumours.

Authors:  C M King; R H Reznek; J E Dacie; J A Wass
Journal:  Clin Radiol       Date:  1994-05       Impact factor: 2.350

10.  Pathogenesis of hypoglycemia in insulinoma patients: suppression of hepatic glucose production by insulin.

Authors:  R A Rizza; M W Haymond; C A Verdonk; L J Mandarino; J M Miles; F J Service; J E Gerich
Journal:  Diabetes       Date:  1981-05       Impact factor: 9.461

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.